BOSTON SCIENTIFIC CORPORATION Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges
BOSTON SCIENTIFIC CORPORATION (BSX) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges of $27.00 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges · last filed 2026-02-17
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges $27.00M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges $12.00M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges $14.00M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges $6.00M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges |
|---|---|
| 2025-12-31 | $27.00M 10-K · filed 2026-02-17 |
| 2024-12-31 | $12.00M 10-K · filed 2026-02-17 |
| 2023-12-31 | $14.00M 10-K · filed 2025-02-18 |
| 2022-12-31 | $6.00M 10-K · filed 2024-02-20 |
| 2021-12-31 | $14.00M 10-K · filed 2023-02-23 |
| 2020-12-31 | $23.00M 10-K · filed 2022-02-23 |
| 2019-12-31 | $20.00M 10-K · filed 2021-02-23 |
| 2018-12-31 | $12.00M 10-K · filed 2020-02-25 |
| 2017-12-31 | $12.00M 10-K · filed 2019-02-19 |
| 2016-12-31 | $14.00M 10-K · filed 2018-02-20 |
| 2015-12-31 | $17.00M 10-K · filed 2017-02-23 |
| 2014-12-31 | $20.00M 10-K · filed 2016-02-24 |
| 2013-12-31 | $17.00M 10-K · filed 2015-02-25 |
| 2012-12-31 | $13.00M 10-K · filed 2014-02-26 |
| 2011-12-31 | $20.00M 8-K · filed 2013-05-29 |
| 2010-12-31 | $17.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |